Allogene Therapeutics, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 13 | 0.0% | 9,467 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 12 | 0.0% | 9,416 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 11 | 0.0% | 9,409 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 14 | 0.0% | 9,409 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 289 | 0.0% | 135,554 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 358 | 0.0% | 127,869 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 326 | 0.0% | 139,981 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 482 | 0.0% | 107,830 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 361 | 0.0% | 112,458 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 303 | 0.0% | 95,464 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 515 | 0.0% | 103,598 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 522 | 0.0% | 105,642 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 672 | 0.0% | 106,767 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 1,141 | 0.0% | 105,608 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 1,220 | 0.0% | 107,002 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 869 | 0.0% | 95,443 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 1,533 | 0.0% | 102,768 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 2,580 | 0.0% | 100,400 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 2,444 | 0.0% | 93,700 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 2,870 | 0.0% | 81,299 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 2,061 | 0.0% | 81,643 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 3,079 | 0.0% | 81,637 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 3,132 | 0.0% | 73,142 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 1,139 | 0.0% | 58,585 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 1,531 | 0.0% | 58,930 | 12/31/2019 |